ATE541041T1 - Produktion von rekombinantem aav mit hohem titer - Google Patents
Produktion von rekombinantem aav mit hohem titerInfo
- Publication number
- ATE541041T1 ATE541041T1 AT03754869T AT03754869T ATE541041T1 AT E541041 T1 ATE541041 T1 AT E541041T1 AT 03754869 T AT03754869 T AT 03754869T AT 03754869 T AT03754869 T AT 03754869T AT E541041 T1 ATE541041 T1 AT E541041T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- recombinant aav
- raav
- high titre
- titre recombinant
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 2
- 241000702421 Dependoparvovirus Species 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/252,182 US7091029B2 (en) | 2002-09-23 | 2002-09-23 | High titer recombinant AAV production |
| PCT/US2003/030098 WO2004027048A2 (en) | 2002-09-23 | 2003-09-23 | High titer recombinant aav production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE541041T1 true ATE541041T1 (de) | 2012-01-15 |
Family
ID=31992891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03754869T ATE541041T1 (de) | 2002-09-23 | 2003-09-23 | Produktion von rekombinantem aav mit hohem titer |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7091029B2 (de) |
| EP (1) | EP1546343B1 (de) |
| AT (1) | ATE541041T1 (de) |
| AU (1) | AU2003272672B2 (de) |
| CA (1) | CA2499386C (de) |
| ES (1) | ES2378883T3 (de) |
| NZ (1) | NZ562881A (de) |
| WO (1) | WO2004027048A2 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070202587A1 (en) * | 2002-09-23 | 2007-08-30 | Applied Genetic Technologies Corporation | Recombinant AAV production in mammalian cells |
| EP2242840B1 (de) | 2008-01-29 | 2019-07-24 | Applied Genetic Technologies Corporation | Rekombinante adeno-assoziierte virusproduktion mit bhk zellen in suspension |
| DK2943567T3 (en) | 2013-01-08 | 2018-01-02 | Genzyme Corp | USE OF INOS INHIBITORS TO INCREASE VIRAL YIELD IN CULTURE |
| US11078464B2 (en) * | 2013-08-30 | 2021-08-03 | Amgen Inc. | High titer recombinant AAV vector production in adherent and suspension cells |
| EP3132051B1 (de) * | 2014-04-15 | 2019-03-20 | Applied Genetic Technologies Corporation | Codon-optimierte nukleinsäure zur codierung eines retinitis-pigmentosa-gtpase-regulators (rpgr) |
| JP6204582B2 (ja) * | 2014-05-15 | 2017-09-27 | 高砂電気工業株式会社 | マイクロ蠕動ポンプ |
| EP3242945B1 (de) | 2015-01-07 | 2021-09-01 | Universitat Autònoma de Barcelona | Einzelvektor-genkonstrukt mit insulin- und glucokinasegenen |
| WO2019152841A1 (en) | 2018-02-01 | 2019-08-08 | Homology Medicines, Inc. | Adeno-associated virus compositions for pah gene transfer and methods of use thereof |
| AU2019215152A1 (en) | 2018-02-01 | 2020-08-20 | Homology Medicines, Inc. | Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof |
| US11306329B2 (en) | 2018-02-19 | 2022-04-19 | City Of Hope | Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof |
| GB201806333D0 (en) * | 2018-04-18 | 2018-05-30 | Glaxosmithkline Ip Dev Ltd | Parvovirus vector production |
| US20220098556A1 (en) * | 2019-01-25 | 2022-03-31 | Biogen Ma Inc. | Seed culture process for aav production |
| CN114450411A (zh) | 2019-04-01 | 2022-05-06 | 特纳亚治疗股份有限公司 | 具有工程化衣壳的腺相关病毒 |
| WO2021041986A1 (en) * | 2019-08-28 | 2021-03-04 | University Of Florida Research Foundation, Incorporated | Improved production of recombinant aav using embryonated avian eggs |
| TW202140791A (zh) | 2020-01-13 | 2021-11-01 | 美商霍蒙拉奇醫藥公司 | 治療苯酮尿症之方法 |
| TW202208632A (zh) | 2020-05-27 | 2022-03-01 | 美商同源醫藥公司 | 用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法 |
| JP7415042B2 (ja) | 2020-10-09 | 2024-01-16 | テナヤ セラピューティクス， インコーポレイテッド | プラコフィリン２遺伝子治療の方法および組成物 |
| WO2022109241A1 (en) | 2020-11-20 | 2022-05-27 | University Of Florida Research Foundation, Incorporated | Improved aav production using potassium chloride |
| AR125468A1 (es) * | 2021-04-27 | 2023-07-19 | Novartis Ag | Sistema de producción de vectores virales |
| WO2023201207A1 (en) | 2022-04-11 | 2023-10-19 | Tenaya Therapeutics, Inc. | Adeno-associated virus with engineered capsid |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2626383B1 (fr) * | 1988-01-27 | 1991-10-25 | Commissariat Energie Atomique | Procede de microscopie optique confocale a balayage et en profondeur de champ etendue et dispositifs pour la mise en oeuvre du procede |
| US6686200B1 (en) * | 1993-08-31 | 2004-02-03 | Uab Research Foundation | Methods and compositions for the large scale production of recombinant adeno-associated virus |
| US5965441A (en) | 1996-11-13 | 1999-10-12 | The General Hospital Coporation | HSV/AAV hybrid amplicon vectors |
| GB9721909D0 (en) * | 1997-10-17 | 1997-12-17 | Cantab Pharma Res | Gene delivery vectors and their uses |
| US7258858B2 (en) * | 1997-12-24 | 2007-08-21 | University Of Guelph | Method of identifying high immune response animals |
| AU5689699A (en) * | 1998-08-24 | 2000-03-14 | Uab Research Foundation | Methods of producing high titer recombinant adeno-associated virus |
| AU6151899A (en) * | 1998-09-23 | 2000-04-10 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods of treating chronic pain |
| WO2001066782A1 (en) * | 2000-03-03 | 2001-09-13 | The Board Of Trustees Of The Leland Stanford Junior University | Adeno-associated viral compositions and methods |
-
2002
- 2002-09-23 US US10/252,182 patent/US7091029B2/en not_active Expired - Lifetime
-
2003
- 2003-09-23 CA CA2499386A patent/CA2499386C/en not_active Expired - Lifetime
- 2003-09-23 AU AU2003272672A patent/AU2003272672B2/en not_active Expired
- 2003-09-23 AT AT03754869T patent/ATE541041T1/de active
- 2003-09-23 NZ NZ562881A patent/NZ562881A/en not_active IP Right Cessation
- 2003-09-23 WO PCT/US2003/030098 patent/WO2004027048A2/en not_active Ceased
- 2003-09-23 ES ES03754869T patent/ES2378883T3/es not_active Expired - Lifetime
- 2003-09-23 EP EP03754869A patent/EP1546343B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2378883T3 (es) | 2012-04-18 |
| US20040058439A1 (en) | 2004-03-25 |
| WO2004027048A3 (en) | 2004-07-15 |
| WO2004027048A2 (en) | 2004-04-01 |
| EP1546343A4 (de) | 2007-12-19 |
| CA2499386C (en) | 2014-12-09 |
| AU2003272672A1 (en) | 2004-04-08 |
| AU2003272672B2 (en) | 2006-04-06 |
| NZ562881A (en) | 2009-07-31 |
| US7091029B2 (en) | 2006-08-15 |
| EP1546343A2 (de) | 2005-06-29 |
| CA2499386A1 (en) | 2004-04-01 |
| EP1546343B1 (de) | 2012-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1546343A4 (de) | Produktion von rekombinantem aav mit hohem titer | |
| WO2003018820A3 (en) | Mutant recombinant adeno-associated viruses related applications | |
| FR20C1016I1 (de) | ||
| CY1121446T1 (el) | Αλληλουχιες αδενο-σχετιζομενου ιου (aav) οροτυπου 8, φορεις που περιεχουν αυτες και χρησεις για αυτους | |
| WO2003006616A3 (en) | Pseudotyped adeno-associated viruses and uses thereof | |
| MX342639B (es) | Virus de la influenza recombinantes de alta titulacion para vacunas y terapia genica. | |
| DE60235039D1 (de) | Egvii-endoglucanase und dafür codierende nukleinsäuren | |
| MX9603002A (es) | Procedimiento para la preparacion de virus asociados a los adenovirus (aav), recombinantes, y usos de los mismos. | |
| AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
| CY1112140T1 (el) | Ανασυνδυασμενοι ιοι γριππης για εμβολια και γονιδιακη θεραπεια | |
| AU2002305450A1 (en) | Proteomimetic compounds and methods | |
| WO2005111220A3 (en) | Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences | |
| CY1116285T1 (el) | Ανασυνδυασμενες ν-γλυκοζυλιωμενες πρωτεϊνες απο προκαρυωτικα κυτταρα | |
| BRPI0411363A (pt) | seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas | |
| DE60040147D1 (de) | Methoden und zusammensetzungen zur reduktion des tumor-nekrosis-faktor-spiegels (tnf) bei tnf-assoziierten erkrankungen | |
| PT2292780T (pt) | Clados de vírus adenoassociados (aav), sequências, vetores que as contêm, e suas utilizações | |
| CY1110868T1 (el) | Ελαχιστη αλληλουχια dna που δρα ως μονωτης της χρωματινης και η χρηση της στην πρωτεϊνικη εκφραση | |
| WO2002024234A3 (en) | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye | |
| EP1461079A4 (de) | Mutanten von hüllglykoproteinen des human immunodeficiency virus und deren verwendung | |
| DE60233532D1 (de) | An proteinphosphatase 2a bindende synthetische ode anwendungen | |
| EP1572889A4 (de) | Faktor-viii-polypeptide auf hohem expressionsniveau codierende nukleinsäure- und aminosäuresequenzen und verwendungsverfahren | |
| WO2008021140A3 (en) | Recombinant aav production in mammalian cells | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| DK1278868T3 (da) | Muteret form af arginindeiminase | |
| WO2002062296A3 (en) | Methods and compositions useful for stimulating an immune response |